Ian Clements - Nov 24, 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role: Chief Financial Officer
Signature: /s/ Jody Howe, Attorney-in-Fact
Stock symbol: MIRM
Transactions as of: Nov 24, 2021
Transactions value $: $20,505
Form type: 4
Date filed: 11/29/2021, 08:49 PM
Previous filing: Nov 15, 2021
Next filing: Jan 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MIRM	Common Stock	Purchase	$10.1K	+700	+4.09%	$14.40	17.8K	Nov 24, 2021	Direct	F1
transaction	MIRM	Common Stock	Purchase	$10.4K	+750	+4.21%	$13.90	18.6K	Nov 26, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.

Content

The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.